American Century Companies’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
91,501
+5,794
| +7% | +$63.9K | ﹤0.01% | 2290 |
|
|
2025
Q1 | $765K | Buy |
85,707
+7,776
| +10% | +$69.4K | ﹤0.01% | 2348 |
|
|
2024
Q4 | $733K | Buy |
77,931
+8,289
| +12% | +$78K | ﹤0.01% | 2364 |
|
|
2024
Q3 | $561K | Buy |
69,642
+12,031
| +21% | +$97K | ﹤0.01% | 2437 |
|
|
2024
Q2 | $489K | Buy |
57,611
+6,026
| +12% | +$51.1K | ﹤0.01% | 2451 |
|
|
2024
Q1 | $463K | Buy |
51,585
+8,708
| +20% | +$78.1K | ﹤0.01% | 2473 |
|
|
2023
Q4 | $482K | Buy |
42,877
+6,754
| +19% | +$75.9K | ﹤0.01% | 2371 |
|
|
2023
Q3 | $312K | Buy |
36,123
+4,641
| +15% | +$40.1K | ﹤0.01% | 2450 |
|
|
2023
Q2 | $326K | Buy |
31,482
+10,278
| +48% | +$106K | ﹤0.01% | 2367 |
|
|
2023
Q1 | $228K | Buy |
21,204
+8,506
| +67% | +$91.3K | ﹤0.01% | 2381 |
|
|
2022
Q4 | $142K | Buy |
+12,698
| New | +$142K | ﹤0.01% | 2397 |
|
|
2017
Q4 | – | Sell |
-28,279
| Closed | -$968K | – | 1361 |
|
|
2017
Q3 | $968K | Buy |
28,279
+198
| +0.7% | +$6.78K | ﹤0.01% | 1148 |
|
|
2017
Q2 | $1.12M | Sell |
28,081
-2,672
| -9% | -$106K | ﹤0.01% | 1122 |
|
|
2017
Q1 | $1.13M | Buy |
+30,753
| New | +$1.13M | ﹤0.01% | 1120 |
|